본문 바로가기
KERD
논문KCI 등재

척수강 내 약물 주입술

The Intrathecal Drug Administration System

2

조회

0

다운로드

3

인용

0

참고문헌

키워드

초록

The intrathecal drug administration system (ITDAS) has recently been introduced for treating chronic intractable pain patients who have failed with conservative pain treatments. The obvious advantages of its use are the direct intrathecal delivery of drugs, which yields reduced adverse effects and the increased strength of drugs, as compared to its oral or intravenous route. This article offers a review of the ITDAS with a brief review of its evidence-based effectiveness, the technical approach, and the complications.

Abstract

The intrathecal drug administration system (ITDAS) has recently been introduced for treating chronic intractable pain patients who have failed with conservative pain treatments. The obvious advantages of its use are the direct intrathecal delivery of drugs, which yields reduced adverse effects and the increased strength of drugs, as compared to its oral or intravenous route. This article offers a review of the ITDAS with a brief review of its evidence-based effectiveness, the technical approach, and the complications.

참고문헌 (50)

  1. "Expert Working Group of the European Association for Palliative Care: Morphine in cancer pain: modes of administration", BMJ, 312, pp.823~826 (1996)
  2. Sylvester RK, "The conversion challenge: from intrathecal to oral morphine", Am J Hosp Palliat Care, 21, pp.143~147 (2004)
  3. Yaksh TL, "Narcotic analgestics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques", Pain, 4, pp.299~359 (1978)
  4. 이상진, "척수강 내 약물 주입기의 이식 −증례보고−", The Korean Journal of Pain, 22(1), pp.68~73 (2009), 대한통증학회
  5. 서경수, "복합부위통증증후군 환자에게 시행한 매몰식 펌프를 이용한 지주막하강 내 약물투입 −증례보고−", The Korean Journal of Pain, 22(1), pp.74~77 (2009), 대한통증학회
  6. Yaksh TL, "Analgesia mediated by a direct spinal action of narcotics", Science, 192, pp.1357~1358 (1976)
  7. Wang JK, "Pain relief by intrathecally applied morphine in man", Anesthesiology, 50, pp.149~151 (1979)
  8. Onofrio BM, "Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin", Clin Proc, 56, pp.516~520 (1981)
  9. Leavens ME, "Intrathecal and intraventricular morphine for pain in cancer patients: initial study", J Neurosurg, 56, pp.241~245 (1982)
  10. Rico RC, "Use of intrathecal and epidural morphine for pain relief in patients with malignant diseases: a preliminary report", J Med, 13, pp.223~231 (1982)
  11. Auld AW, "Intraspinal narcotic analgesia in the treatment of chronic pain", Spine, 10, pp.777~781 (1985)
  12. Paice JA, "Intraspinal morphine for chronic pain: a retrospective, multicenter study", J Pain Symptom Manage, 11, pp.71~80 (1996)
  13. Brazenor GA, "Long term intrathecal administration of morphine: a comparison of bolus injection via reservoir with continuous infusion by implanted pump", Neurosurgery, 21, pp.484~491 (1987)
  14. Johnston J, "Shiley INFUSAID Pump technology", Ann N Y Acad Sci, 531, pp.57~65 (1988)
  15. Belverud S, "Intrathecal pumps", Neurotherapeutics, 5, pp.114~122 (2008)
  16. Smith HS, "Intrathecal drug delivery", Pain Physician, 11, pp.89~104 (2008)
  17. Patel VB, "Systematic review of intrathecal infusion systems for long-term management of chronic non-cancer pain", Pain Physician, 12, pp.345~360 (2009)
  18. Anderson VC, "A prospective study of long- term intrathecal morphine in the management of chronic nonmalignant pain", Neurosurgery, 44, pp.289~300 (1999)
  19. Angel IF, "Intrathecal morphine pump as a treatment option in chronic pain of nonmalignant origin", Surg Neurol, 49, pp.92~98 (1998)
  20. Hassenbusch SJ, "Long-term intraspinal infusions of opioids in the treatment of neuropathic pain", J Pain Symptom Manage, 10, pp.527~543 (1995)
  21. Winkelmuller M, "Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology", J Neurosurg, 85, pp.458~467 (1996)
  22. Roberts LJ, "Outcome of intrathecal opioids in chronic non-cancer pain", Eur J Pain, 5, pp.353~361 (2001)
  23. Thimineur MA, "Intrathecal opioid treatment for chronic non-malignant pain: a 3-year prospective study", Pain, 109, pp.242~249 (2004)
  24. Rauck RL, "Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain", J Pain, 4, pp.441~447 (2003)
  25. Smith TJ, "An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM)", Ann Oncol, 16, pp.825~833 (2005)
  26. Anderson VC, "Intrathecal hydromorphone for chronic nonmalignant pain: a retrospective study", Pain Med, 2, pp.287~297 (2001)
  27. Doggrell SA, "Intrathecal ziconotide for refractory pain", Expert Opin Investig Drugs, 13, pp.875~877 (2004)
  28. Staats PS, "Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial", JAMA, 291, pp.63~70 (2004)
  29. Van Dongen RT, "Intrathecal coadministration of bupivacaine diminishes morphine dose progression during long-term intrathecal infusion in cancer patients", Clin J Pain, 15, pp.166~172 (1999)
  30. Deer TR, "Clinical experience with intrathecal bupivacaine in combination with opioid for the treatment of chronic pain related to failed back surgery syndrome and metastatic cancer pain of the spine", Spine J, 2, pp.274~278 (2002)
  31. Classen AM, "Stability of admixture containing morphine sulfate, bupivacaine hydrochloride, and clonidine hydrochloride in an implantable infusion system", J Pain Symptom Manage, 28, pp.603~611 (2004)
  32. Raphael JH, "Long-term experience with implanted intrathecal drug administration systems for failed back syndrome and chronic mechanical low back pain", BMC Musculoskelet Disord, 3, pp.17~17 (2002)
  33. Nordberg G, "Pharmacokinetic aspects of intrathecal morphine analgesia", Anesthesiology, 60, pp.448~454 (1984)
  34. Moore A, "Spinal fluid kinetics of morphine and heroin", Clin Pharmacol Ther, 35, pp.40~45 (1984)
  35. Payne R, "CSF distribution of morphine, methadone and sucrose after intrathecal injection", Life Sci, 37, pp.1137~1144 (1985)
  36. Faura CC, "Systematic review of factors affecting the ratios of morphine and its major metabolites", Pain, 74, pp.43~53 (1998)
  37. Pasternak GW, "Morphine-6-glucuronide, a potent mu agonist", Life Sci, 41, pp.2845~2849 (1987)
  38. Hassenbusch SJ, "Clinical realities and economic considerations: economics of intrathecal therapy", J Pain Symptom Manage, 14, pp.36~48 (1997)
  39. Hassenbusch SJ, "Cost modeling for alternate routes of administration of opioids for cancer pain", Oncology, 13, pp.63~67 (1999)
  40. Koulousakis A, "Intrathecal opioids for intractable pain syndromes", Acta Neurochir Suppl, 97, pp.43~48 (2007)
  41. Kumar K, "Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy", Surg Neurol, 55, pp.79~86 (2001)
  42. "Medtronic Synchromed II programmable infusion system clinical reference guide: pain management" (2004), Medtronic Inc
  43. Krames ES, "Clinical realities and economic considerations: patient selection in intrathecal therapy", J Pain Symptom Manage, 14, pp.3~13 (1997)
  44. France JC, "The use of intrathecal morphine for analgesia after posterolateral lumbar fusion: a prospective, double-blind, randomized study", Spine, 22, pp.2272~2277 (1997)
  45. Krames ES, "Intrathecal infusional therapies for intractable pain: patient management guidelines", J Pain Symptom Manage, 8, pp.36~46 (1993)
  46. Yaksh TL, "Retrospective consideration of the doses of morphine given intrathecally by chronic infusion in 163 patients by 19 physicians", Pain, 31, pp.211~223 (1987)
  47. Ruan X, "Drug-related side effects of long-term intrathecal morphine therapy", Pain Physician, 10, pp.357~366 (2007)
  48. Miele VJ, "A review of intrathecal morphine therapy related granulomas", Eur J Pain, 10, pp.251~261 (2006)
  49. Singh PK, "Management of pericatheter cerebrospinal fluid leak after intrathecal implantation of a drug delivery system", Am J Hosp Palliat Care, 25, pp.237~239 (2008)
  50. "Medtronic Synchromed II programmable infusion system clinical reference guide: surgical procedures" (2004), Medtronic Inc

관련 논문AI추천

척수강 내 약물 주입기의 이식 −증례보고−김용철, 김장현, 김현주, 남상건, 이상진, 이상철대한통증학회 · The Korean Journal of Pain2009 · 제22권 제1호Catheter Obstruction of Intrathecal Drug Administration System -A Case Report-이평복, Eun Joo Choi, Francis Sahngun Nahm, Seok Myeon Rhee대한통증학회 · The Korean Journal of Pain2012 · 제25권 제1호Continuous Intrathecal Morphine Administration for Cancer Pain Management Using an Intrathecal Catheter Connected to a Subcutaneous Injection Port: A Retrospective Analysis of 22 Terminal Cancer Patients in Korean Population김종해, 정진용, 조민수대한통증학회 · The Korean Journal of Pain2013 · 제26권 제1호Intrathecal Morphine Infusion Therapy in Management of Chronic Pain: Present and Future Implementation in Korea김용철, 김은정, 문지연, 박근석, 유용재연세대학교의과대학 · Yonsei Medical Journal2016 · 제57권 제2호복합부위통증증후군 환자에게 시행한 매몰식 펌프를 이용한 지주막하강 내 약물투입 −증례보고−김찬, 김세영, 박경언, 서경수, 한경림대한통증학회 · The Korean Journal of Pain2009 · 제22권 제1호Role of Catheter’s Position for Final Results in Intrathecal Drug Delivery. Analysis Based on CSF Dynamics and Specific Drugs ProfilesAsensio Samper Juan Marcos, De Andres Jose, Fabregat-Cid Gustavo, Perotti Luciano, Villanueva Vicente대한통증학회 · The Korean Journal of Pain2013 · 제26권 제4호

이 간행물의 다른 논문 (13건)